Taken together, these data clearly show that SYT13 expression is preferential to resistant OMNs, as well as relatively resilient spinal motor neurons remaining in end-stage ALS patient tissues, suggesting that SYT13 could play a beneficial role in these cells. The gene discussed is SYT13; the disease is amyotrophic lateral sclerosis.